BlackRock U.S. Industry Rotation ETF (INRO) News

Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm

Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm PR Newswire NEW YORK, July 1...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical...

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a...

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a...

Form 8-K - Current report

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 8-K - Current report

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

The STRIDE study did not meet its primary or secondary efficacy endpoint The company to suspend mavodelpar...

Form EFFECT - Notice of Effectiveness